These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 29368827
21. Propofol Induced Hyperkalemia and Its Management in End Stage Renal Disease Patients. Virmani S, Onuchic A, El-Ali IM, Trivedi RD. Conn Med; 2016 Sep; 80(8):491-493. PubMed ID: 29782787 [Abstract] [Full Text] [Related]
22. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. Farese S, Kruse A, Pasch A, Dick B, Frey BM, Uehlinger DE, Frey FJ. Kidney Int; 2009 Oct; 76(8):877-84. PubMed ID: 19641483 [Abstract] [Full Text] [Related]
23. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW. Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019 [Abstract] [Full Text] [Related]
24. Hyperkalemia and Electrocardiogram Manifestations in End-Stage Renal Disease. Rafique Z, Hoang B, Mesbah H, Pappal R, Peacock FW, Juarez-Vela R, Szarpak L, Kuo DC. Int J Environ Res Public Health; 2022 Dec 02; 19(23):. PubMed ID: 36498212 [Abstract] [Full Text] [Related]
27. Control of serum potassium during fasting in patients with end-stage renal disease. Gifford JD, Rutsky EA, Kirk KA, McDaniel HG. Kidney Int; 1989 Jan 02; 35(1):90-4. PubMed ID: 2651754 [Abstract] [Full Text] [Related]
28. Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. Maher T, Schambelan M, Kurtz I, Hulter HN, Jones JW, Sebastian A. J Lab Clin Med; 1984 Mar 02; 103(3):432-45. PubMed ID: 6366094 [Abstract] [Full Text] [Related]
34. Brugada phenocopy induced by hyperkalemia. Zhuo M, Li J, Lecker SH. Kidney Int; 2019 Feb 02; 95(2):471. PubMed ID: 30665578 [No Abstract] [Full Text] [Related]
35. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. Eur J Prev Cardiol; 2014 Mar 02; 21(3):299-309. PubMed ID: 24191305 [Abstract] [Full Text] [Related]
36. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis. Kim DM, Chung JH, Yoon SH, Kim HL. Nephrol Dial Transplant; 2007 Nov 02; 22(11):3273-6. PubMed ID: 17616536 [Abstract] [Full Text] [Related]
37. [Diagnosis and treatment of disorders of the potassium balance with special reference to infusion therapy]. Düsing R, Kramer HJ. Infusionsther Klin Ernahr; 1975 Dec 02; 2(6):409-10,413-6. PubMed ID: 1205585 [Abstract] [Full Text] [Related]
38. Potassium Disorders: Hypokalemia and Hyperkalemia. Viera AJ, Wouk N. Am Fam Physician; 2015 Sep 15; 92(6):487-95. PubMed ID: 26371733 [Abstract] [Full Text] [Related]
39. Electrocardiographic manifestations of hyperkalemia in hemodialysis patients. Nemati E, Taheri S. Saudi J Kidney Dis Transpl; 2010 May 15; 21(3):471-7. PubMed ID: 20427871 [Abstract] [Full Text] [Related]